| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |